GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Baldwin Group $1.006 billion credit facilities financing
We advised the borrower on the refinancing and amendment
Oscar Health $410 million convertible senior subordinated notes and capped call transactions
The 2.25% convertible notes are due 2030
Norwegian Cruise Line Holdings comprehensive refinancing transactions
The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
Bombardier $250 million senior notes offering
The investment-grade senior notes are due 2033
Natura sale of Avon International to Regent
We are advising Natura on the sale
Century Communities $500 million senior notes offering and concurrent redemption
The high-yield notes are due 2033
ICG sale of majority stake in TIME Education to Nautic Investment
We advised Intermediate Capital Group on the transaction
GrowthCurve Capital acquisition of PlanHub
We advised GrowthCurve Capital on the transaction
TPG KRW733 billion sale of Samhwa to KKR
We advised TPG on the transaction